<P> Postmarketing surveillance uses a number of approaches to monitor drug and device safety , including spontaneous reporting databases , prescription event monitoring , electronic health records , patient registries , and record linkage between health databases . These data are reviewed to highlight potential safety concerns in a process known as data mining . </P>
methods of post marketing surveillance in clinical research
spontaneous reporting databases prescription event monitoring electronic health records patient registries record linkage between health databases